Anastasios Georgotas

2.3k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Anastasios Georgotas is a scholar working on Pharmacology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Anastasios Georgotas has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 15 papers in Psychiatry and Mental health and 5 papers in Biological Psychiatry. Recurrent topics in Anastasios Georgotas's work include Treatment of Major Depression (24 papers), Electroconvulsive Therapy Studies (8 papers) and Tryptophan and brain disorders (5 papers). Anastasios Georgotas is often cited by papers focused on Treatment of Major Depression (24 papers), Electroconvulsive Therapy Studies (8 papers) and Tryptophan and brain disorders (5 papers). Anastasios Georgotas collaborates with scholars based in United States, Canada and United Kingdom. Anastasios Georgotas's co-authors include Steven H. Ferris, ‌Barry Reisberg, Stacy Salob, E. Franssen, Robert E. McCue, Jeffrey Borenstein, Thomas B. Cooper, Eitan Friedman, I. Chang and Arnold J. Friedhoff and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Anastasios Georgotas

38 papers receiving 1.7k citations

Hit Papers

Behavioral symptoms in Alzheimer's disease: phenomenology... 1987 2026 2000 2013 1987 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
    1987 894 citations ‌Barry Reisberg, Jeffrey Borenstein et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anastasios Georgotas United States 19 1.2k 718 285 244 227 39 1.9k
M. W. P. Carney United Kingdom 22 1.1k 0.9× 728 1.0× 274 1.0× 375 1.5× 267 1.2× 75 3.0k
Paul J. Goodnick United States 31 1.4k 1.2× 777 1.1× 253 0.9× 332 1.4× 256 1.1× 91 3.2k
U. G. Ahlfors Denmark 16 1.5k 1.2× 618 0.9× 130 0.5× 274 1.1× 179 0.8× 29 2.2k
S. J. Dencker Sweden 20 1.9k 1.6× 625 0.9× 147 0.5× 275 1.1× 214 0.9× 70 2.7k
Alan M. Mellow United States 28 1.3k 1.1× 408 0.6× 410 1.4× 153 0.6× 520 2.3× 62 3.0k
Matthias J. Müller Germany 28 1.0k 0.9× 368 0.5× 197 0.7× 322 1.3× 305 1.3× 61 1.9k
Sanjay Gupta United States 27 1.2k 1.0× 396 0.6× 307 1.1× 135 0.6× 131 0.6× 109 2.3k
I. Gergel United States 11 936 0.8× 953 1.3× 385 1.4× 621 2.5× 194 0.9× 28 2.3k
William M. Glazer United States 29 2.1k 1.7× 301 0.4× 256 0.9× 175 0.7× 225 1.0× 103 3.0k
Douglas L. Boggs United States 18 989 0.8× 711 1.0× 217 0.8× 112 0.5× 171 0.8× 30 1.8k

Countries citing papers authored by Anastasios Georgotas

Since Specialization
Citations

This map shows the geographic impact of Anastasios Georgotas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Georgotas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Georgotas more than expected).

Fields of papers citing papers by Anastasios Georgotas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Georgotas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Georgotas. The network helps show where Anastasios Georgotas may publish in the future.

Co-authorship network of co-authors of Anastasios Georgotas

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Georgotas. A scholar is included among the top collaborators of Anastasios Georgotas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Georgotas. Anastasios Georgotas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Georgotas, Anastasios, et al.. (1989). The Effects of Mood Changes and Antidepressants on the Cognitive Capacity of Elderly Depressed Patients. International Psychogeriatrics. 1(2). 135–143. 30 indexed citations
2.
Georgotas, Anastasios, et al.. (1989). Factors affecting the delay of antidepressant effect in responders to Nortriptyline and Phenelzine. Psychiatry Research. 28(1). 1–9. 44 indexed citations
3.
McCue, Robert E., Anastasios Georgotas, R F Suckow, & Thomas B. Cooper. (1989). 10-Hydroxynortriptyline and treatment effects in elderly depressed patients. Journal of Neuropsychiatry. 1(2). 176–180. 3 indexed citations
4.
McCue, Robert E., et al.. (1989). Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. Journal of Psychiatric Research. 23(1). 73–79. 13 indexed citations
5.
McCue, Robert E. & Anastasios Georgotas. (1989). Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine. Biological Psychiatry. 25(7). A57–A57.
6.
Georgotas, Anastasios. (1988). How Effective and Safe Is Continuation Therapy in Elderly Depressed Patients?. Archives of General Psychiatry. 45(10). 929–929. 62 indexed citations
7.
Georgotas, Anastasios, Robert E. McCue, Eitan Friedman, & Thomas B. Cooper. (1987). Response of Depressive Symptoms to Nortriptyline, Phenelzine and Placebo. The British Journal of Psychiatry. 151(1). 102–106. 41 indexed citations
8.
Georgotas, Anastasios, et al.. (1987). Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients. Life Sciences. 40(22). 2137–2143. 24 indexed citations
9.
Georgotas, Anastasios, Robert E. McCue, Eitan Friedman, & Thomas B. Cooper. (1987). A Placebo-Controlled Comparison of the Effect of Nortriptyline and Phenelzine on Orthostatic Hypotension in Elderly Depressed Patients. Journal of Clinical Psychopharmacology. 7(6). 413???416–413???416. 21 indexed citations
10.
Reisberg, ‌Barry, Jeffrey Borenstein, Stacy Salob, et al.. (1987). Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.. PubMed. 48 Suppl. 9–15. 894 indexed citations breakdown →
11.
Georgotas, Anastasios, Robert E. McCue, Eitan Friedman, et al.. (1986). Relationship of platelet MAO activity to characteristics of major depressive illness. Psychiatry Research. 19(4). 247–256. 21 indexed citations
12.
Georgotas, Anastasios & Robert E. McCue. (1986). Benefits and Limitations of Major Pharmacological Treatment for Depression. American Journal of Psychotherapy. 40(3). 370–376. 2 indexed citations
13.
Georgotas, Anastasios, et al.. (1985). Hypothalamic - Pituitary - Adrenocortical Function in Geriatric Depression: Diagnostic and Treatment implications. Indian Journal of Psychological Medicine. 8(1). 33–42. 18 indexed citations
14.
Georgotas, Anastasios, et al.. (1983). The treatment of affective disorders in the elderly.. PubMed. 19(2). 226–37. 10 indexed citations
15.
Usdin, Earl, et al.. (1983). Frontiers in Neuropsychiatric Research. Palgrave Macmillan UK eBooks. 53 indexed citations
16.
Georgotas, Anastasios, Eliot Friedman, Mary K. McCarthy, et al.. (1983). Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.. PubMed. 18(2). 195–205. 56 indexed citations
17.
Georgotas, Anastasios, Menachem Krakowski, & Samuel Gershon. (1982). Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression. American Journal of Psychiatry. 139(8). 1057–1058. 7 indexed citations
18.
Reisberg, ‌Barry, et al.. (1982). Relationship between cognition and mood in geriatric depression.. PubMed. 18(4). 191–3. 4 indexed citations
19.
Georgotas, Anastasios, et al.. (1981). Safety data on zimelidine hydrochloride following an overdose. Acta Psychiatrica Scandinavica. 63(s290). 257–261. 9 indexed citations
20.
Friedman, Ernest H., et al.. (1980). The antidepressant effects of trazodone and inhibition of platelet serotonin reuptake.. PubMed. 4(4). 293–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. W. P. Carney Breakdown of academic impact, for papers by Paul J. Goodnick Breakdown of academic impact, for papers by U. G. Ahlfors Breakdown of academic impact, for papers by S. J. Dencker Breakdown of academic impact, for papers by Alan M. Mellow Breakdown of academic impact, for papers by Matthias J. Müller Breakdown of academic impact, for papers by Sanjay Gupta Breakdown of academic impact, for papers by I. Gergel Breakdown of academic impact, for papers by William M. Glazer Breakdown of academic impact, for papers by Douglas L. Boggs
Rankless by CCL
2026